SCHEMBL9933561

SCHEMBL9933561

CCCCCCCCC=CCCCCCCCC(=O)OCC(CCCC)CCCCCC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.66
TDP1 Q9NUW8 2/20 0.65
CYP3A4 P08684 1/20 0.65
TSHR P16473 1/20 0.65
ATM Q13315 1/20 0.65
PRKCE Q02156 1/20 0.63
PRKCQ Q04759 1/20 0.63
PRKCD Q05655 1/20 0.63
PRKCA P17252 1/20 0.63
LPAR1 Q92633 8/20 0.59
ENPP2 Q13822 4/20 0.59
LPAR3 Q9UBY5 4/20 0.59
LPAR4 Q99677 3/20 0.59
LPAR2 Q9HBW0 3/20 0.59
LPAR5 Q9H1C0 2/20 0.59
CES2 O00748 1/20 0.59
LPAR6 P43657 1/20 0.59
TRPV1 Q8NER1 1/20 0.59
RECQL P46063 1/20 0.56
BLM P54132 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20969290 1.00 DGKA (0.66) DGKATDP1CYP3A4TSHRATM
SCHEMBL20969291 1.00 DGKA (0.66) DGKATDP1CYP3A4TSHRATM
SCHEMBL3747702 1.00 DGKA (0.66) DGKATDP1CYP3A4TSHRATM
SCHEMBL8956548 1.00 DGKA (0.66) DGKATDP1CYP3A4TSHRATM
SCHEMBL9933462 0.98 DGKA (0.68) DGKATDP1CYP3A4TSHRATM
SCHEMBL3849574 0.98 DGKA (0.68) DGKATDP1CYP3A4TSHRATM
SCHEMBL9933260 0.98 DGKA (0.68) DGKATDP1CYP3A4TSHRATM
SCHEMBL10784004 0.98 DGKA (0.68) DGKATDP1CYP3A4TSHRATM
SCHEMBL10784010 0.98 DGKA (0.68) DGKATDP1CYP3A4TSHRATM
SCHEMBL8956657 0.98 DGKA (0.68) DGKATDP1CYP3A4TSHRATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3913039-B1 BLEND OF ESTER COMPOUNDS KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) 2024-01-31 EP disclosed
US-11795134-B2 Ester compounds, method for the production thereof and use thereof KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) 2023-10-24 US disclosed
CN-110431218-B Novel ester compound, process for producing the same, and use thereof 慕尼黑克吕伯尔润滑器股份两合公司 2022-09-13 CN disclosed
US-20210061750-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof KLUBER LUBRICATION MUNCHEN SE & Co. KG (DE) 2021-03-04 US disclosed
US-10829436-B2 Ester compounds, method for the production thereof and use thereof KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) 2020-11-10 US disclosed
US-20200140370-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof UNIVERSITÄTSSTR BIELEFELD (DE) 2020-05-07 US disclosed
EP-2550954-B1 VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION NISSHIN OILLIO GROUP LTD (JP) 2020-03-04 EP disclosed
EP-3609988-A1 NOVEL ESTER COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF Klüber Lubrication München SE & Co. KG (DE) 2020-02-19 EP disclosed
EP-2494952-B1 COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC NISSHIN OILLIO GROUP LTD (JP) 2018-02-28 EP disclosed
US-9028850-B2 Composition for cosmetics, cosmetic, method for producing oil-in-water emulsion cosmetic, and two separate layer-type cosmetic THE NISSHIN OILLIO GROUP, LTD. (JP) 2015-05-12 US disclosed
US-9028848-B2 Composition for cosmetics, cosmetic, method for producing oil-in-water emulsion cosmetic, and two separate layer-type cosmetic THE NISSHIN OILLIO GROUP, LTD. (JP) 2015-05-12 US disclosed
US-20130303634-A1 COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC NISSHIN OILLIO GROUP LTD (JP) 2013-11-14 US disclosed
EP-2550954-A1 VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION The Nisshin Oillio Group, Ltd. (JP) 2013-01-30 EP disclosed
US-20130005808-A1 VASELINE-LIKE COMPOSITION AND COSMETIC The Nisshin OilliO Group ,Ltd. (JP) 2013-01-03 US disclosed
CN-102821743-A Vaseline-like composition and cosmetic NISSHIN OILLIO GROUP LTD 2012-12-12 CN disclosed
EP-2494952-A1 COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC The Nisshin Oillio Group, Ltd. (JP) 2012-09-05 EP disclosed
US-20120156271-A1 COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC THE NISSHIN OILLIO GROUP, LTD. (JP) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829436-B2 Ester compounds, method for the production thereof and use thereof CYP46A1, CYP51A1, CEL DGKA 1051/4885TDP1 3922/4885CYP3A4 48/4885
US-11795134-B2 Ester compounds, method for the production thereof and use thereof CYP46A1, CYP17A1, CYP51A1 DGKA 1164/4885TDP1 3965/4885CYP3A4 38/4885
US-20120156271-A1 COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC GK, DGKG, MGLL DGKA 5/4885TDP1 3610/4885CYP3A4 4481/4885
US-20210061750-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof CYP46A1, CEL, CYP51A1 DGKA 1078/4885TDP1 4019/4885CYP3A4 63/4885
US-20200140370-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof CYP46A1, CYP51A1, CEL DGKA 1089/4885TDP1 4323/4885CYP3A4 65/4885
US-20130303634-A1 COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC GK, DGKA, DGKG DGKA 2/4885TDP1 4307/4885CYP3A4 4320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.